Related Experiment Videos

Cardiac surgery in infants with very low birth weight

V M Reddy1, F L Hanley

  • 1Division of Cardiothoracic Surgery, University of California, San Francisco, USA.

Insights

Early surgical repair of congenital heart defects in very low birth weight infants (<1,500 g) is safe and effective. Delaying surgery increases morbidity and offers no benefit for these vulnerable patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Neonatal Intensive Care

Background:

  • Congenital heart defects (CHDs) in low birth weight infants are often managed with delayed definitive repair.
  • This approach is associated with high morbidity.
  • Outcomes for very low birth weight infants (<1,500 g) undergoing early repair are not well-documented.

Purpose of the Study:

  • To evaluate the safety and efficacy of complete surgical repair of CHDs in infants weighing 1,500 g or less.
  • To compare outcomes of early repair versus delayed management in this high-risk population.

Main Methods:

  • Retrospective analysis of 20 infants weighing ≤1,500 g who underwent complete CHD repair (excluding isolated patent ductus arteriosus) since 1990.
  • Inclusion of various complex CHDs: aortic coarctation, VSD, TOF, TGA, truncus arteriosus, TAPVR, DORV, PA-IVS.
  • Modified neonatal cardiopulmonary bypass techniques were employed.

Main Results:

  • 2 early deaths (10%) occurred due to foot gangrene and pulmonary complications; no intracranial hemorrhage was observed.
  • At a median follow-up of 40 months, 1 late death and 4 reinterventions (surgical/catheter) were recorded.
  • No neurological sequelae attributable to surgery were found; postoperative growth approximated controls.

Conclusions:

  • Delaying repair of CHDs in low and very low birth weight infants offers no benefit and increases preoperative morbidity.
  • Complete repair of simple and complex CHDs is feasible and yields good early and medium-term results in this population.
  • Early surgical correction is recommended for symptomatic infants with CHDs, especially those weighing <1,500 g.

Related Concept Videos